Reuters logo
BRIEF-Neuren Pharmaceuticals posts HY net loss attributable of $3.6 mln
August 24, 2017 / 9:29 AM / a month ago

BRIEF-Neuren Pharmaceuticals posts HY net loss attributable of $3.6 mln

Aug 24 (Reuters) - Neuren Pharmaceuticals Ltd

* HY operating revenue $19,000, down 93.8 percent

* HY net loss attributable to members $3.6 million versus loss of $7.4 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below